This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Nu Skin Enterprises (NUS) is a Top-Ranked Value Stock: Should You Buy?
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Helen of Troy (HELE) Up on Solid Leadership Brands & Online Sales
by Zacks Equity Research
Helen of Troy (HELE) is focused on making solid investments in the Leadership Brands. Also, the company is gaining from its consistent online sales.
Ulta Beauty (ULTA) Gains on Growth in Skincare, Digital Wing
by Zacks Equity Research
Ulta Beauty (ULTA) is gaining from growth across beauty categories, especially skincare, Its omni-channel efforts are encouraging.
7 Low Price-to-Sales Stocks to Buy in the Current Market
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like FL, GIII, NUS, MET, PIPR, HIBB, and SMP are promising picks.
Inter Parfums (IPAR) Benefits From Alliances & Product Launches
by Zacks Equity Research
Inter Parfums (IPAR) is focused on product launches that will boost assortment strength. The company concentrates on expanding its business through new licenses and acquisitions.
Coty (COTY) More Than Doubles in a Year: Will Momentum Stay?
by Zacks Equity Research
Coty (COTY) is focused on its core strategies that include achieving solid e-commerce momentum, strengthening presence in China and solidifying its foothold in the prestige category.
Helen of Troy (HELE) Rewards Shareholders, Unveils New Buybacks
by Zacks Equity Research
Helen of Troy (HELE) approves repurchase of shares worth $500 million to return capital not otherwise deployed toward strategic buyouts or core business growth.
Value Stocks & ETFs to Buy Now
by Neena Mishra
Here is what you need to know about value investing...
Why Is Nu Skin (NUS) Down 8.2% Since Last Earnings Report?
by Zacks Equity Research
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Estee Lauder Companies (EL) Up More than 25% YTD: Will it Stay?
by Zacks Equity Research
The Estee Lauder Companies' (EL) Skin Care portfolio is performing well. The company's solid online business is yielding amid pandemic-led hurdles.
Scoop Up These 7 Low Price-to-Sales Stocks Reflecting Strength
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like FL, MT, NUS, MET, PIPR, KBH, and SMP are promising picks.
Coty (COTY) Q4 Loss Wider Than Estimates, Revenues Increase
by Zacks Equity Research
Coty's (COTY) fourth-quarter fiscal 2021 results reflect higher revenues on growth across all regions and channels. However, loss in the quarter was wider than the consensus mark.
Inter Parfums (IPAR) Surges More Than 60% in a Year: Here's Why
by Zacks Equity Research
Inter Parfums (IPAR) has been focused on undertaking product launches to strengthen assortments. The company is expanding its business through strategic partnerships.
7 Low Price-to-Sales Stocks to Replenish Your Portfolio
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like HIBB, BSET, NUS, MET, MT, KBH, and SMP are promising picks.
Nu Skin (NUS) Q2 Earnings Beat Estimates, Sales Grow Y/Y
by Zacks Equity Research
Nu Skin's (NUS) second-quarter 2021 earnings and revenues increase year over year on growth in sales leaders. Also, management raises 2021 earnings view.
Nu Skin Enterprises (NUS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Nu Skin (NUS) delivered earnings and revenue surprises of 8.49% and 0.21%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Nu Skin (NUS) Queued for Q2 Earnings: Key Things to Note
by Zacks Equity Research
Nu Skin's (NUS) second-quarter 2021 performance is likely to reflect gains from the company's efforts to strengthen sales leader and expand customer. Also, online strength has been a driver.
Nu Skin Enterprises (NUS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Estee Lauder Companies (EL) Up 61% in a Year: Here's How
by Zacks Equity Research
The Estee Lauder Companies (EL) has a strong online business. The company's Skin Care portfolio is performing well.
Coty's (COTY) Innovation Solid, Launches Touch-Less Fragrance Tester
by Zacks Equity Research
Coty (COTY) will introduce a digitally-enabled touch-less fragrance tester at beauty retailers in the next 12 months. Management expects to improve in-store sales via the launch.
Nu Skin (NUS) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Nu Skin Enterprises (NUS) has been struggling lately, but the selling pressure may be coming to an end soon
Helen of Troy's (HELE) Q1 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Helen of Troy's (HELE) first-quarter fiscal 2022 results reflect growth in earnings and net sales on strength in all segments.
Buy These 5 Low Leverage Stocks to Keep Debt Risks Away
by Aparajita Dutta
The crux of safe investment lies in choosing a company that is not overburdened with debt as a debt-free stock is almost impossible to find. You may buy NUS, SON, NX, WRI and TD.
Inter Parfums (IPAR)-Salvatore Ferragamo Deal to Fuel Growth
by Zacks Equity Research
Inter Parfums (IPAR) inks a deal with Salvatore Ferragamo to fuel growth across the fragrance business.
New Strong Buy Stocks for July 2nd
by Zacks Equity Research
PIPR, TA, NUS, BKR, and LYB have been added to the Zacks Rank #1 (Strong Buy) List on July 2, 2021.